In Conversation with Abraham Lin, co-founder and CEO, Orbits Oncology   David is a biopharmaceutical researcher with more than 10 years of experience in drug discovery, spanning cancer research, virology, and cell and gene therapy. His primary focus is preclinical cancer research for small molecule therapeutics, informed by his study of targeted therapeutics in lung … Continue reading [CBA Conference 2024] Conference speaker highlight